Table of Contents
Gavi revealed its five-year plan in the global vaccine forum hosted in partnership with the French Republic and the African Union. In the coming five years it is aiming to vaccinate 120 million girls and save 1.5 million individuals with the help of the “human papillomavirus (HPV)” Vaccine. This vaccine would protect girls from genital warts, cervical cancer and other infections. Additionally, it is going to vaccinate children with four doses of Malaria.
Fundraising Goal of Gavi
The global vaccine organization seeks $9 billion from Foundations and Governments to arrange funding for their immunization program in the poorest countries. As per the reports “Global Alliance for Vaccines and Immunisation (Gavi)” aims to raise funds for this vaccination and complete its commitment between 2026-2030. The organization revealed that it had already raised a sum of $2.4 billion in which $1.58billion is contributed by the U.S. This amount of $9B was finalized
Image Source: Reuters
Vaccination goal for Africa
The vaccine group has also launched a $1.2 B scheme to bolster vaccination production within Africa and also launched an African Vaccine Manufacturing accelerator. Africa depends significantly on imported vaccines, currently sourcing nearly 99 percent of its routine vaccines from abroad. The COVID-19 pandemic has reignited a long-standing debate within African and global communities: What is required for Africa to produce its vaccines?
Image Source: McKinsey
Mission and Impact of Gavi
Its mission is to provide vaccination against harmful diseases for low-income countries. As of 2020 the consistent effort made by Gavi protected the lives of around 1B Children. The vaccination for the diseases mainly includes vaccination for measles, malaria stated by CEO of Gavi Sania Nishtar.
It is also aimed at providing vaccination to the highest number of children in the shortest possible lifespan. Additionally, it is committed to reaching the vaccination number of children to around 500 in the next five years.
The documents of the Gavi board state that the alliance requires $ 11.9 billion for its work from 2026. The rest of the fund is going to come from COVID-19 financing
Financial Bottlenecks and Solutions
Nishtar also mentioned that it is a tough time to manage funds when the economy is suffering due to ongoing country conflicts, and climate change that further stretched the demand for global health.
She also acknowledged the fact that “Gavi has never had to make trade-offs before,” she stated that they have diverse range of vaccines but due to resource limitations from donors they are unable to dispatch the vaccines.
However, She said that their consistent fundraising efforts would definitely help in eliminating these issues soon in the coming years.
Goals and Future plans for Gavi
In the future, it is planning to further expand its vaccine portfolio in the coming years. For instance, introducing a mpox vaccine stockpile which is actually a Dengue vaccine. Furthermore, it’s also going to add a vaccine for dengue in its program in future as the climate change is contributing to the risk of dengue outbreaks.
Moreover, it is also planning to establish a program namely “Day Zero”, that is allocating $500 million in the pandemic fund to take quick action for vulnerable outbreaks in the future.
Overview of Gavi
Gavi is an international firm that works in close coordination with private and public sectors and shares a common goal of protecting lives and immunizing people against disease. This organization is working consistently towards creating a more equitable and sustainable health domain so that poor people can also gain access to vaccines.
